AGP Executive Report
Last update: 6 hours agoCross-border health access: Macau’s MOP700 health e-vouchers stay the same for 2026, but use is set to expand into Guangdong clinics and outpatient departments starting next month via “Macao One Account.” Disease watch: Macau confirmed its first imported malaria case of the year—an adult man who traveled to Nigeria and is in serious condition in hospital. Chronic disease progress: The Health Bureau says about 89% of registered hypertension patients received treatment in 2024, with measurement points now at 337 locations across the city. Regional health services: Social Security Fund briefings in Hengqin rolled out new cross-border convenience under revised Macau social security rules, including time spent in Hengqin counting toward Macau. Big pharma momentum: Bristol Myers Squibb and Hengrui signed a deal worth up to US$15.2B for 13 early-stage oncology/hematology/immunology programs—another sign Macau’s wider Greater Bay Area health ecosystem keeps pulling in global capital.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
